Literature DB >> 8954898

Expression and characterization of a truncated, soluble, low-density lipoprotein receptor.

K A Dirlam1, D G Gretch, D J LaCount, S L Sturley, A D Attie.   

Abstract

The low-density lipoprotein (LDL) receptor mediates the clearance of apolipoprotein B- and E-containing lipoproteins from the bloodstream. In the current study, we characterized the binding properties of the amino terminus of the LDL receptor. We produced a recombinant baculovirus that encoded the first 354 amino acids, including the endogenous signal sequence, of the human LDL receptor. This truncated receptor protein (LDL-R354) was secreted from recombinant baculovirus-infected Spodoptera frugiperda (Sf-21) cells. Upon electrophoresis, LDL-R354 migrated with a mobility of 55,000. Treatment of cells with tunicamycin decreased the size of the truncated receptor, suggesting the presence of asparagine-linked carbohydrates. Nonreducing SDS-PAGE resulted in at least three discernible bands with M(r)s consistent with the truncated receptor existing as monomers and multimers, suggesting the possibility of intermolecular disulfide cross-linking. All forms of the truncated receptor bound LDL on a ligand blot in a calcium-dependent manner. The purified truncated receptor bound 125I-LDL with high affinity in a competitive binding assay (IC50 = 0.8 microgram/ml). LDL-R354 also bound calcium. This interaction was sensitive to the conformation of the ligand binding domain, as reduction of the disulfide bonds greatly decreased the affinity of the receptor for calcium. The ligand and calcium binding activities of this truncated receptor protein demonstrate that the ligand binding domain of the LDL receptor can fold into a functionally active protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954898     DOI: 10.1016/s1046-5928(96)90129-1

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

1.  Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B.

Authors:  Donald L Gillian-Daniel; Paul W Bates; Angie Tebon; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Gene structure and molecular phylogeny of the linker chains from the giant annelid hexagonal bilayer hemoglobins.

Authors:  Christine Chabasse; Xavier Bailly; Sophie Sanchez; Morgane Rousselot; Franck Zal
Journal:  J Mol Evol       Date:  2006-07-12       Impact factor: 2.395

3.  Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB.

Authors:  Daniel A Blasiole; Angie T Oler; Alan D Attie
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

4.  Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins.

Authors:  Ji Miao; Joel T Haas; Praveen Manthena; Yanning Wang; Enpeng Zhao; Bhavapriya Vaitheesvaran; Irwin J Kurland; Sudha B Biddinger
Journal:  J Lipid Res       Date:  2014-02-10       Impact factor: 5.922

5.  The role of calcium in lipoprotein release by the low-density lipoprotein receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

6.  Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients.

Authors:  Amy E Levenson; Mary E Haas; Ji Miao; Rebecca J Brown; Sarah D de Ferranti; Ranganath Muniyappa; Sudha B Biddinger
Journal:  Endocrinology       Date:  2016-01-29       Impact factor: 4.736

7.  Characterization of lipophorin receptor (LpR) mediating the binding of high density lipophorin (HDLp) in the silkworm, Bombyx mori.

Authors:  G Ravikumar; K V Vardhana; H K Basavaraja
Journal:  J Insect Sci       Date:  2011       Impact factor: 1.857

8.  Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis.

Authors:  Ji Miao; Alisha V Ling; Praveen V Manthena; Mary E Gearing; Mark J Graham; Rosanne M Crooke; Kevin J Croce; Ryan M Esquejo; Clary B Clish; David Vicent; Sudha B Biddinger
Journal:  Nat Commun       Date:  2015-04-07       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.